| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 01/09/2001 | US6172237 Process for preparing eprosartan |
| 01/09/2001 | US6172090 Side effect reduction by administering an insulin sensitivity enhancer such as pioglitazone hydrochloride with a biguanide such as metformin |
| 01/09/2001 | US6172089 Pharmaceutical composition |
| 01/09/2001 | US6172082 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/09/2001 | US6172058 Nervous system disorders; psychological disorders |
| 01/09/2001 | US6172057 Antiinflammatory agents; antiarthritic agents; antitumor agents |
| 01/09/2001 | US6171522 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials |
| 01/04/2001 | WO2001000599A1 Benzamide derivatives, insecticides for agricultural and horticultural use and usage thereof |
| 01/04/2001 | WO2001000595A1 Method for producing 2-heterocyclyl methyl benzoic acid derivatives |
| 01/04/2001 | WO2001000586A1 Compounds as selective agonists at alpha 2b or 2b/2c adrenergic receptors |
| 01/04/2001 | WO2001000578A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
| 01/04/2001 | WO2001000575A1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same |
| 01/04/2001 | WO2001000558A1 Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediates |
| 01/04/2001 | CA2377287A1 Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediates |
| 01/04/2001 | CA2370500A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
| 01/03/2001 | EP1064278A1 Cationic di-benzene dyeing agents, use for oxidation dyeing of keratin fibres, dyeing compositions and dyeing method |
| 01/03/2001 | EP1064274A1 Benzenesulfonamide derivatives and their use as medicaments |
| 01/03/2001 | EP1064268A1 Novel cationic compounds, their use as coupling agents for oxidation dyeing of keratinous fibres, dyeing compositions and dyeing methods |
| 01/03/2001 | EP1064267A1 Novel cationic coupling agents, their use for oxidation dyeing of keratinous fibres, dyeing compositions and dyeing methods |
| 01/03/2001 | EP1064264A1 Cytotoxic metal chelators and methods for making and using same |
| 01/03/2001 | EP0787127B1 5-lipoxygenase inhibitors |
| 01/03/2001 | EP0656890B1 Novel method for preparing ergothioneine |
| 01/03/2001 | CN1278805A Novel heterocyclioally substituted and a-hydroxycarboxlic acid derivatives, method for producing the same and their use as endothelin receptor antagonists |
| 01/03/2001 | CN1278793A Sulfonyl derivatives |
| 01/03/2001 | CN1278789A 9,10-Dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
| 01/03/2001 | CN1278721A IL-8 receptor antagonists |
| 01/03/2001 | CN1060163C Acylated aminoalknimidazoles and aminoalkyl triazoles |
| 01/02/2001 | US6169100 Pharmaceutical composition |
| 01/02/2001 | US6169099 Pharmaceutical composition |
| 01/02/2001 | US6169089 Nitric oxide synthase inhibitors; treatment of arthritis |
| 01/02/2001 | CA2012314C Imidazoline compounds |
| 01/02/2001 | CA2009604C Diaryl-substituted heterocyclic compounds, their preparation and drugs and cosmetics obtained therefrom |
| 01/02/2001 | CA1341164C 1-hydroxyethyl-azole derivatives, a process for their preparation and their use as plant growth regulators and fungicides |
| 12/28/2000 | WO2000078812A1 Method and compounds for inhibiting activity of serine elastases |
| 12/28/2000 | WO2000078727A1 Process for the preparation of imidazole derivatives |
| 12/28/2000 | WO2000078726A1 Imidazoline derivatives for the treatment of diabetes, especially type ii diabetes |
| 12/28/2000 | WO2000078725A1 Synthesis of substituted amidines |
| 12/28/2000 | WO2000078724A2 Imidazolinderivatives their preparation and their pharmaceutical use |
| 12/28/2000 | WO2000078363A1 Radiolabeled farnesyl-protein transferase inhibitors |
| 12/28/2000 | WO2000078311A1 Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
| 12/28/2000 | WO1999052493A3 Compounds that inhibit the binding of integrins to their receptors |
| 12/28/2000 | DE19929348A1 Pure 2-heterocyclylmethyl-benzoic acid derivative preparation in high yield, for use as pharmaceutical or agrochemical intermediate, from phthalide compound and nitrogen-containing heterocycle |
| 12/28/2000 | CA2375287A1 Production method of imidazole derivatives |
| 12/28/2000 | CA2375229A1 Method and compounds for inhibiting activity of serine elastases |
| 12/27/2000 | EP1062264A2 Enzyme inhibitors |
| 12/27/2000 | EP1062212A1 Heterocyclyl anthracyclinone derivatives |
| 12/27/2000 | EP1062208A1 Hetaryl-substituted benzyl phenyl ethers, method for the production thereof, and their use for combating harmful fungi and animal pests |
| 12/27/2000 | CN1278247A Alpha-hydroxy, amino and -fluoro derivatives of beta-sulphenyl hydroxamic acids matrix metalloproteinases inhibitors |
| 12/27/2000 | CN1278244A Dipeptide nitriles |
| 12/26/2000 | US6166221 Intermediate for 4-(hydroxy-5-(1-imidazolyl)-2-methylbenzyl)-3,5-dimethylbenzoic acid useful as a thromboxane synthetase inhibitor and an agent for the prophylaxis and treatment of diabetes |
| 12/26/2000 | US6166220 Ethylenically unsaturated imidazidolidinone monomers |
| 12/26/2000 | US6166216 Compounds useful as neuro-protective agents |
| 12/26/2000 | US6166064 Antiinflammatory agents; antiarthritic agents |
| 12/26/2000 | US6166060 Antihistamines; sleep disorders; central nervous system disorders |
| 12/26/2000 | US6166050 Treatment of inflammatory and autoimmune diseases |
| 12/26/2000 | US6166043 Insulin sensitivity enhancer such as pioglitazone in combination with a biguanide such as metformin |
| 12/26/2000 | US6166042 Pharmaceutical composition |
| 12/21/2000 | WO2000076991A1 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
| 12/21/2000 | WO2000076489A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 12/21/2000 | WO2000051993A3 Dihetero-substituted metalloprotease inhibitors |
| 12/21/2000 | WO2000044709A3 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS |
| 12/21/2000 | DE19928033A1 Verwendung von cyclischen Enaminen als Lichtschutzmittel The use of cyclic enamines as light stabilizers |
| 12/21/2000 | CA2375551A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 12/21/2000 | CA2374627A1 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
| 12/20/2000 | EP1060734A2 Use of cyclic enamines as sun protection agents |
| 12/20/2000 | EP1060165A1 Method for preparing n-substituted heterocyclic derivatives using a phase-transfer catalyst |
| 12/20/2000 | EP0801642B1 Novel sulfamate compound containing n-substituted carbamoyl group and method for preparing the same |
| 12/19/2000 | US6162924 Process for halohydrin preparation |
| 12/19/2000 | US6162922 4'-((2-alkyl or alkoxy-4-oxo-1,3-diazaspiro(4.4)non-1-en-3-yl)methyl)(1,1'-bip henyl)-2-car bonitrile and its salts using phase transfer catalysis. |
| 12/19/2000 | US6162824 Nervous system disorders; psychological disorders |
| 12/19/2000 | US6162821 Preparation and use of ortho-sulfonamide heteroarly hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 12/19/2000 | US6162814 Antiarthritic agents; cardiovascular disorders; antitumor agents |
| 12/19/2000 | US6162812 Pharmaceutical compositions containing HIV protease inhibitors and methods of their use |
| 12/19/2000 | US6162444 Cosmetic or pharmaceutical compositions |
| 12/19/2000 | CA2188109C Process for preparing alkylimidazolidone (meth)acrylates |
| 12/14/2000 | WO2000075172A2 FACTOR VIIa INHIBITORS |
| 12/14/2000 | WO2000075138A1 Oxime derivatives, process for the preparation thereof and pesticides |
| 12/14/2000 | WO2000075117A1 Compositions and methods for inhibiting cell death |
| 12/14/2000 | WO2000075104A1 Novel method for preparing optically active alpha-aminonitriles |
| 12/14/2000 | WO2000075101A1 Excitatory amino acid receptor modulators |
| 12/14/2000 | WO2000046187A3 Antizyme modulators and their use |
| 12/14/2000 | CA2375843A1 Compositions and methods for inhibiting cell death |
| 12/13/2000 | EP1059302A1 Factor VIIa inhibitors |
| 12/13/2000 | EP1058679A1 Synthesis of epothilones, intermediates thereto and analogues therof |
| 12/13/2000 | CN1276785A N-aroylphenylalanine derivs. |
| 12/13/2000 | CN1276727A Growth hormone secretagogues |
| 12/12/2000 | US6160134 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
| 12/12/2000 | US6159995 Substituted diaminocarboxylic acids |
| 12/07/2000 | WO2000073280A1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 12/07/2000 | WO2000073262A1 Polymerizable, olefinically unsaturated monomers |
| 12/07/2000 | WO2000073258A1 Therapeutically and/or nutritionally enhanced derivatives of active ingredients and orally administrable compositions containing same |
| 12/07/2000 | WO2000072956A1 Preparation and use of ionic liquids in microwave-assisted chemical transformations |
| 12/07/2000 | WO2000072845A1 Il-8 receptor antagonists |
| 12/07/2000 | WO2000072840A1 Il-8 receptor antagonists |
| 12/07/2000 | CA2375683A1 Il-8 receptor antagonists |
| 12/07/2000 | CA2374295A1 Il-8 receptor antagonists |
| 12/06/2000 | EP1057817A1 Novel compounds, hardening accelerator, resin composition, and electronic part device |
| 12/06/2000 | EP1057816A1 Method for producing heteroaromatic aldehydes |
| 12/06/2000 | EP1056726A1 Solid phase synthesis of 1-aminohydantoins |
| 12/06/2000 | EP0597088B1 Novel imidazole derivatives, their preparation and therapeutic applications |